Independent Portfolio Consultants’s Athenahealth, Inc. ATHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$64K Sell
458
-157
-26% -$19.6K 0.03% 486
2017
Q1
$69K Sell
615
-265
-30% -$30.9K 0.02% 518
2016
Q4
$93K Sell
880
-45
-5% -$4.84K 0.03% 459
2016
Q3
$117K Sell
925
-50
-5% -$6.36K 0.04% 429
2016
Q2
$135K Sell
975
-220
-18% -$29.1K 0.04% 405
2016
Q1
$166K Buy
1,195
+15
+1% +$2.06K 0.05% 384
2015
Q4
$190K Sell
1,180
-250
-17% -$38.6K 0.06% 340
2015
Q3
$191K Sell
1,430
-570
-29% -$74.4K 0.04% 349
2015
Q2
$229K Buy
2,000
+400
+25% +$47.8K 0.05% 342
2015
Q1
$191K Buy
1,600
+475
+42% +$63.3K 0.04% 370
2014
Q4
$164K Buy
+1,125
New +$141K 0.03% 409
2014
Q3
Sell
-213
Closed -$27K 982
2014
Q2
$27K Buy
+213
New +$27.5K 0.01% 737

Other funds holding ATHN

Independent Portfolio Consultants's ATHN Position: Q2 2017 in Review

Independent Portfolio Consultants reduced its Athenahealth, Inc. (ATHN) stake by 26% in Q2 2017, selling an estimated $19.6K and leaving 458 shares worth $64K. The position accounts for 0.03% of the portfolio, ranked #486.

Independent Portfolio Consultants first reported a position in ATHN in Q2 2014 and has held it in 12 quarters since. The position peaked at $229K in Q2 2015. 226 funds tracked by Wall St. Rank hold ATHN as of Q2 2017.

  • Independent Portfolio Consultants held 458 shares of Athenahealth, Inc. worth $64K as of Q2 2017.
  • Independent Portfolio Consultants sold 157 Athenahealth, Inc. shares in Q2 2017, an estimated $19.6K.
  • Athenahealth, Inc. made up 0.03% of Independent Portfolio Consultants's portfolio in Q2 2017, its #486 holding.
  • Independent Portfolio Consultants first reported a position in Athenahealth, Inc. in Q2 2014 and has held it in 12 quarters since.
  • Independent Portfolio Consultants's Athenahealth, Inc. position peaked at $229K in Q2 2015.
  • 226 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.